tiprankstipranks
Trending News
More News >
ABVC BioPharma, Inc. (ABVC)
NASDAQ:ABVC
US Market

ABVC BioPharma (ABVC) Financial Statements

Compare
123 Followers

ABVC BioPharma Financial Overview

ABVC BioPharma's market cap is currently $52.98M. The company's EPS TTM is $-0.054; its P/E ratio is -9.32; ABVC BioPharma is scheduled to report earnings on November 17, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 509.59K$ 152.43K$ 969.78K$ 355.80K$ 483.05K
Gross Profit$ 508.83K$ -149.61K$ 683.37K$ 350.71K$ 464.33K
Operating Income$ -4.71M$ -6.77M$ -15.11M$ -11.71M$ -8.51M
EBITDA$ -4.34M$ -6.33M$ -15.20M$ -10.97M$ -10.37M
Net Income$ -4.90M$ -7.79M$ -16.42M$ -12.84M$ -9.79M
Balance Sheet
Cash & Short-Term Investments$ 928.55K$ 796.09K$ 1.47M$ 5.94M$ 5.00M
Total Assets$ 7.54M$ 7.78M$ 10.93M$ 13.70M$ 14.77M
Total Debt$ 3.20M$ 2.77M$ 3.41M$ 3.34M$ 6.77M
Net Debt$ 2.34M$ 2.05M$ 2.02M$ -2.49M$ 1.77M
Total Liabilities$ 6.82M$ 6.53M$ 6.34M$ 4.83M$ 8.94M
Stockholders' Equity$ 1.23M$ 1.55M$ 4.45M$ 8.84M$ 6.60M
Cash Flow
Free Cash Flow$ -1.81M$ -4.21M$ -7.52M$ -7.62M$ -4.56M
Operating Cash Flow$ -1.81M$ -4.19M$ -7.40M$ -7.60M$ -4.56M
Investing Cash Flow$ 0.00$ -360.19K$ -1.72M$ -805.97K$ -225.43K
Financing Cash Flow$ 1.98M$ 3.87M$ 4.01M$ 10.00M$ 9.57M
Currency in USD

ABVC BioPharma Earnings and Revenue History

ABVC BioPharma Debt to Assets

ABVC BioPharma Cash Flow

ABVC BioPharma Forecast EPS vs Actual EPS